Unnamed: 0,title,date,stock,sentiment
1408114.0,20 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-06-02 07:32:00-04:00,ZIOP,neutral
1408115.0,Ziopharm Oncology Highlights Presentation Of Clinical Data For Controlled IL-12 For Treatment Of Recurrent Glioblastoma At 2020 American Society Of Clinical Oncology,2020-05-29 08:17:00-04:00,ZIOP,neutral
1408116.0,"The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant",2020-05-29 07:22:00-04:00,ZIOP,positive
1408117.0,"Shares of several healthcare companies are trading higher amid market strength. Strength potentially related to coronavirus efforts including testing, vaccine development and treatment measures from several names in the sector.",2020-05-28 12:33:00-04:00,ZIOP,positive
1408118.0,"Ziopharm Oncology Announces Management Transition, Dr. David Mauney Steps Down As President",2020-05-27 16:16:00-04:00,ZIOP,neutral
1408119.0,The Week Ahead In Biotech: ASCO Presentations In The Spotlight,2020-05-24 14:40:00-04:00,ZIOP,neutral
1408120.0,"Shares of several healthcare companies are trading higher in sympathy with the overall market amid strength in oil, strong earnings from Lowe's and optimism towards a US economic rebound.",2020-05-20 11:19:00-04:00,ZIOP,positive
1408121.0,"HC Wainwright & Co. Reiterates Buy on ZIOPHARM Oncology, Lowers Price Target to $5.5",2020-05-11 07:22:00-04:00,ZIOP,negative
1408122.0,ZIOPHARM Oncology Q1 EPS $(0.090) Beats $(0.630) Estimate,2020-05-07 16:27:00-04:00,ZIOP,neutral
1408123.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,ZIOP,negative
1408124.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,ZIOP,neutral
1408125.0,Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several U.S. hotspots may be peaking. A sooner peak could mean a sooner return to economic activity.,2020-04-06 11:47:00-04:00,ZIOP,positive
1408126.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus package boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 10:58:00-04:00,ZIOP,positive
1408127.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,ZIOP,positive
1408128.0,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",2020-03-17 08:48:00-04:00,ZIOP,neutral
1408129.0,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",2020-03-13 07:52:00-04:00,ZIOP,negative
1408130.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,ZIOP,negative
1408131.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,ZIOP,negative
1408132.0,Stocks That Hit 52-Week Lows On Wednesday,2020-03-11 11:41:00-04:00,ZIOP,negative
1408133.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,ZIOP,positive
1408134.0,"Benzinga's Top Upgrades, Downgrades For March 4, 2020",2020-03-04 10:08:00-05:00,ZIOP,positive
1408135.0,"Cantor Fitzgerald Initiates Coverage On ZIOPHARM Oncology with Overweight Rating, Announces $6 Price Target",2020-03-04 05:10:00-05:00,ZIOP,negative
1408136.0,"Raymond James Maintains Outperform on ZIOPHARM Oncology, Lowers Price Target to $5.5",2020-03-03 07:34:00-05:00,ZIOP,negative
1408137.0,ZIOPHARM Oncology Q4 EPS $(0.09) Misses $(0.08) Estimate,2020-03-02 16:11:00-05:00,ZIOP,negative
1408138.0,"Earnings Scheduled For March 2, 2020",2020-03-02 04:08:00-05:00,ZIOP,neutral
1408139.0,"The Week Ahead In Biotech: COVID-19 Stocks In The Spotlight, Earnings Taper Off",2020-02-29 14:52:00-05:00,ZIOP,neutral
1408140.0,80 Biggest Movers From Yesterday,2020-02-11 04:44:00-05:00,ZIOP,neutral
1408141.0,58 Stocks Moving In Monday's Mid-Day Session,2020-02-10 12:14:00-05:00,ZIOP,neutral
1408142.0,ZIOPHARM Oncology shares are trading higher. Not currently seeing company-specific news.,2020-02-10 11:44:00-05:00,ZIOP,positive
1408143.0,90 Biggest Movers From Yesterday,2020-02-06 05:15:00-05:00,ZIOP,neutral
1408144.0,68 Stocks Moving In Wednesday's Mid-Day Session,2020-02-05 12:16:00-05:00,ZIOP,neutral
1408145.0,ZIOPHARM Oncology shares are trading lower after the company priced a 27.83 million share common stock offering at $3.25/share.,2020-02-05 09:21:00-05:00,ZIOP,positive
1408146.0,Ziopharm Prices ~27.83M Share Offering At $3.25/Share,2020-02-05 09:08:00-05:00,ZIOP,positive
1408147.0,8 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-02-05 07:43:00-05:00,ZIOP,neutral
1408148.0,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",2020-02-05 07:43:00-05:00,ZIOP,neutral
1408149.0,6 Biotechnology Stocks Moving In Wednesday's Pre-Market Session,2020-02-05 07:42:00-05:00,ZIOP,neutral
1408150.0,36 Stocks Moving in Wednesday's Pre-Market Session,2020-02-05 07:23:00-05:00,ZIOP,neutral
1408151.0,14 Stocks Moving In Tuesday's After-Hours Session,2020-02-04 17:04:00-05:00,ZIOP,neutral
1408152.0,ZIOPHARM shares are trading lower after the company reported a common stock offering of no disclosed size.,2020-02-04 16:07:00-05:00,ZIOP,negative
1408153.0,"Ziopharm Oncology Reports Common Stock Offering, No Size Disclosed",2020-02-04 16:03:00-05:00,ZIOP,negative
1408154.0,Ziopharm Highlights Recent Publications In Peer-Reviewed Scientific Journals,2020-01-30 08:46:00-05:00,ZIOP,neutral
1408155.0,"UPDATE: Ziopharm Says Amendment Expands T-Cell Receptors Library Licensed From National Cancer Institute To Include Added TCRs Reactive To Mutated KRAs, TP53; Co. Required To Pay NCI $600K In Cash Within 60 Days",2020-01-14 16:05:00-05:00,ZIOP,negative
1408156.0,ZIOPHARM Oncology On Jan. 8 Entered Amendment To Patent License Agreement With National Cancer Institute,2020-01-14 16:05:00-05:00,ZIOP,negative
1408157.0,ZIOPHARM Oncology Option Alert: Jul 17 $6 Calls Sweep (2) near the Ask: 20000 @ $1.2 vs 57 OI; Earnings 3/3 After Close [est] Ref=$4.68,2020-01-14 10:46:00-05:00,ZIOP,positive
1408158.0,ZIOPHARM Oncology Option Alert: Jul 17 $5 Calls Sweep (2) near the Ask: 500 @ $1.0 vs 176 OI; Ref=$4.47,2020-01-02 11:25:00-05:00,ZIOP,positive
1408159.0,ZIOPHARM Oncology Option Alert: Jan 17 $5.5 Calls Sweep (28) near the Ask: 1041 @ $0.201 vs 4036 OI; Ref=$4.9,2019-12-30 11:40:00-05:00,ZIOP,positive
1408160.0,ZIOPHARM Oncology shares are trading higher after the company presented preclinical data validating a rapid personalized manufacture with TCR at the ASH 2019.,2019-12-09 11:24:00-05:00,ZIOP,positive
1408161.0,"Ziopharm Oncology Presents Pre-Clinical Data Validating  ""Rapid Personalized Manufacture"" with TCR at ASH 2019",2019-12-08 09:11:00-05:00,ZIOP,positive
1408162.0,12 Biotech Stocks Primed For A Short Squeeze,2019-12-06 08:00:00-05:00,ZIOP,neutral
1408163.0,ZIOPHARM Oncology Option Alert: Jan 17 $7 Calls Sweep (36) near the Ask: 2192 @ $0.25 vs 7264 OI; Ref=$5.2,2019-12-04 14:18:00-05:00,ZIOP,positive
1408164.0,ZIOPHARM Oncology Option Alert: Jan 17 $7 Calls Sweep (43) near the Ask: 2061 @ $0.201 vs 7264 OI; Ref=$5.118,2019-12-04 14:06:00-05:00,ZIOP,positive
1408165.0,ZIOPHARM Oncology shares are trading higher after the company on Saturday presented clinical data from its controlled IL-12 platform for the treatment of recurrent Glioblastoma.,2019-11-25 08:56:00-05:00,ZIOP,positive
1408166.0,36 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-11-25 08:40:00-05:00,ZIOP,neutral
1408167.0,AstraZeneca CEO: Closing In On A Cancer Cure,2019-11-22 15:39:00-05:00,ZIOP,negative
1408168.0,ZIOPHARM Oncology shares are trading higher on seemingly no company-specific news.,2019-11-13 14:23:00-05:00,ZIOP,neutral
1408169.0,ZIOPHARM Oncology Q3 EPS $(0.43) May Not Compare To $(0.09) Estimate,2019-11-07 16:45:00-05:00,ZIOP,neutral
1408170.0,"The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs",2019-11-07 07:18:00-05:00,ZIOP,negative
1408171.0,Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program,2019-10-28 08:04:00-04:00,ZIOP,neutral
1408172.0,ZIOPHARM Oncology Option Alert: Jan 17 $6 Calls Sweep (2) near the Ask: 1031 @ $0.3 vs 3311 OI; Earnings 11/8 After Close [est] Ref=$4.25,2019-10-11 14:44:00-04:00,ZIOP,positive
1408173.0,12 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-10-03 08:11:00-04:00,ZIOP,neutral
1408174.0,Ziopharm Oncology Announces FDA Clearance Of IND For Rapid Personalized Manufacture Of CD19-Specific CAR-T,2019-10-01 08:00:00-04:00,ZIOP,neutral
1408175.0,30 Stocks Moving in Monday's Pre-Market Session,2019-09-23 08:11:00-04:00,ZIOP,neutral
1408176.0,"Raymond James Resumes Coverage On Ziopharm Oncology With Outperform, PT $6.50",2019-08-23 06:55:00-04:00,ZIOP,neutral
1408177.0,"Raymond James Reinstates Outperform on ZIOPHARM Oncology, Announces $6.5 Price Target",2019-08-23 06:36:00-04:00,ZIOP,neutral
1408178.0,"JPMorgan, Qualcomm And More 'Fast Money Halftime Report' Picks For August 22",2019-08-22 16:45:00-04:00,ZIOP,neutral
1408179.0,ZIOPHARM Oncology Option Alert: Sep 20 $8 Calls Sweep (34) near the Ask: 1799 @ $0.151 vs 718 OI; Ref=$5.41,2019-08-22 14:47:00-04:00,ZIOP,positive
1408180.0,ZIOPHARM Oncology Option Alert: Oct 18 $7 Calls Sweep (35) near the Ask: 2540 @ $0.25 vs 7035 OI; Ref=$5.02,2019-08-22 12:45:00-04:00,ZIOP,positive
1408181.0,Ziopharm Oncology Announces Publication of Positive Results of Phase 1 Monotherapy Trial of Controlled IL-12 in Patients with Recurrent Glioblastoma in Science Translational Medicine,2019-08-14 14:02:00-04:00,ZIOP,positive
1408182.0,ZIOPHARM Oncology Option Alert: Oct 18 $5.5 Calls Sweep (3) near the Ask: 600 @ $0.5 vs 1674 OI; Ref=$5.07,2019-08-14 10:03:00-04:00,ZIOP,positive
1408183.0,Ziopharma Oncology Reports Opinion For Orphan Drug Designation From EMA For Ad-RTS-hIL-12 Plus Veledimex For Treatment Of Glioma,2019-08-08 09:58:00-04:00,ZIOP,neutral
1408184.0,ZIOPHARM Oncology Q2 EPS $(0.09) Misses $(0.08) Estimate,2019-08-08 09:57:00-04:00,ZIOP,negative
1408185.0,"The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering",2019-08-08 07:11:00-04:00,ZIOP,neutral
1408186.0,40 Stocks Moving In Wednesday's Pre-Market Session,2019-08-07 07:46:00-04:00,ZIOP,neutral
1408187.0,"The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings",2019-08-01 07:18:00-04:00,ZIOP,negative
1408188.0,Stocks That Managed to Breach 52-Week Highs Wednesday Morning,2019-07-31 11:01:00-04:00,ZIOP,neutral
1408189.0,"The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster",2019-07-31 07:06:00-04:00,ZIOP,negative
1408190.0,Ziopharm Oncology Shareholder MSD Partners to Exercise $45M of Warrants; Ziopharm Says the Balance Sheet Will Fund Operations into 2021,2019-07-29 08:43:00-04:00,ZIOP,neutral
1408191.0,40 Healthcare Stocks Moving In Friday's After-Market Session,2019-07-29 04:25:00-04:00,ZIOP,neutral
1408192.0,Ziopharm Names Sath Shukla CFO,2019-07-24 08:31:00-04:00,ZIOP,neutral
1408193.0,48 Biggest Movers From Wednesday,2019-07-05 05:08:00-04:00,ZIOP,neutral
1408194.0,33 Stocks Moving In Wednesday's Mid-Day Session,2019-07-03 12:47:00-04:00,ZIOP,neutral
1408195.0,Ziopharm Oncology Initiates Phase 2 Trial Evaluating Combination Therapy Of Controlled IL-12 With Libtayo To Treat Patients With Recurrent Glioblastoma,2019-06-27 16:11:00-04:00,ZIOP,positive
1408196.0,Ziopharm Oncology Completes Enrollment Of Controlled IL-12 Plus Opdivo Phase 1 Combination Trial In Brain Cancer,2019-06-26 08:33:00-04:00,ZIOP,negative
1408197.0,"The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge",2019-06-20 07:25:00-04:00,ZIOP,positive
1408198.0,"The Daily Biotech Pulse: Positive Readouts From Adamas And Ironwood, Sesen Bio To Offer Shares, Stoke Therapeutics Debut",2019-06-19 07:51:00-04:00,ZIOP,positive
1408199.0,ZIOPHARM Oncology Option Alert: Jul 19 $7 Calls Sweep (12) near the Ask: 1000 @ $0.2 vs 347 OI; Earnings 8/7 After Close [est] Ref=$5.82,2019-06-18 09:42:00-04:00,ZIOP,positive
1408200.0,"The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale",2019-06-18 07:31:00-04:00,ZIOP,neutral
1408201.0,ZIOPHARM Oncology Option Alert: Jul 19 $5.5 Calls Sweep (2) near the Ask: 500 @ $0.49 vs 760 OI; Earnings 8/7 After Close [est] Ref=$5.3,2019-06-14 09:35:00-04:00,ZIOP,positive
1408202.0,"The Daily Biotech Pulse:  Hematology And Rheumatology Conference Presentations Take The Spotlight, Eton In-Licenses Epilepsy Drug NDA",2019-06-14 08:47:00-04:00,ZIOP,neutral
1408203.0,"The Daily Biotech Pulse: Savara Slumps On Flunked Trial, NuCana Takes Off, Tetraphase Downsizes",2019-06-13 07:44:00-04:00,ZIOP,negative
1408204.0,50 Biggest Movers From Yesterday,2019-06-13 05:44:00-04:00,ZIOP,neutral
1408205.0,66 Biggest Movers From Yesterday,2019-06-12 04:44:00-04:00,ZIOP,neutral
1408206.0,48 Stocks Moving In Tuesday's Mid-Day Session,2019-06-11 12:36:00-04:00,ZIOP,neutral
1408207.0,Ziopharm Oncology shares are trading higher after the company received FDA clearance for its IND application for Sleeping Beauty TCR-T cell therapy trial.,2019-06-11 11:13:00-04:00,ZIOP,positive
1408208.0,31 Stocks Moving In Tuesday's Pre-Market Session,2019-06-11 08:09:00-04:00,ZIOP,neutral
1408209.0,Ziopharm Oncology Announces FDA Clearance Of IND For Sleeping Beauty TCR-T Cell Therapy Trial At NCI,2019-06-11 08:01:00-04:00,ZIOP,positive
1408210.0,Ziopharm Oncology Provides Positive Clinical Data for Controlled IL-12 for the Treatment of Recurrent Glioblastoma at #ASCO19,2019-06-02 10:17:00-04:00,ZIOP,positive
1408211.0,The Week Ahead In Biotech: ASCO Presentations Pick Up The Pace,2019-06-01 11:37:00-04:00,ZIOP,neutral
1408212.0,"The Daily Biotech Pulse: Inovio's Partner Scales Back R&D Collaboration, Genmab Seeks Nasdaq Listing, Bayer Gets Breakthrough Therapy Designation",2019-05-29 07:38:00-04:00,ZIOP,neutral
1408213.0,Ziopharm Oncology Announces Exclusive License With National Cancer Institute To Identify And Use T-Cell Receptors Targeting Neoantigens For Cancer With Sleeping Beauty Platform,2019-05-28 16:17:00-04:00,ZIOP,negative
1408214.0,ZIOPHARM Oncology Q1 EPS $(0.08) Up From $(0.15) YoY,2019-05-08 17:17:00-04:00,ZIOP,neutral
1408215.0,"The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split",2019-05-08 07:53:00-04:00,ZIOP,negative
1408216.0,Lake Street Initiates Coverage On ZIOPHARM Oncology with Buy Rating,2019-04-04 09:40:00-04:00,ZIOP,neutral
1408217.0,Ziopharma's Lead Asset Snags Fast Track Designation For Cancer Treatment,2019-04-01 10:36:00-04:00,ZIOP,negative
1408218.0,"Laidlaw & Co. Initiates Coverage On ZIOPHARM Oncology with Buy Rating, Announces $7.50 Price Target",2019-04-01 08:58:00-04:00,ZIOP,neutral
1408219.0,ZIOPHARM Oncology shares are trading higher after the FDA granted the company fast track designation for its Ad-RTS-hIL-12.,2019-04-01 08:30:00-04:00,ZIOP,positive
1408220.0,24 Stocks Moving In Monday's Pre-Market Session,2019-04-01 08:14:00-04:00,ZIOP,neutral
1408221.0,A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street,2019-04-01 07:31:00-04:00,ZIOP,neutral
1408222.0,Ziopharm Oncology Receives Fast Track Designation From the FDA for Ad-RTS-hIL-12,2019-04-01 07:05:00-04:00,ZIOP,neutral
1408223.0,ZIOPHARM Oncology Option Alert: Fri $2.5 Calls Sweep (10) near the Ask: 712 @ $0.901 vs 5004 OI; Earnings 5/9 After Close [est] Ref=$3.3,2019-03-12 14:52:00-04:00,ZIOP,positive
1408224.0,ZIOPHARM Oncology Q4 EPS $1.29 May Not Compare To $(0.11) Estimate,2019-03-05 16:04:00-05:00,ZIOP,neutral
1408225.0,"The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings",2019-03-05 07:24:00-05:00,ZIOP,positive
1408226.0,Ziopharm Oncology Completes Enrollment Of Controlled IL-12 Monotherapy Expansion Substudy In Phase 1 Brain Cancer Trial,2019-02-11 07:45:00-05:00,ZIOP,negative
1408227.0,Ziopharm Sends Letter to Shareholders,2019-01-07 16:02:00-05:00,ZIOP,neutral
1408228.0,UPDATE: Ziopharma Oncology Says Co. Believes Stock Price Drop May Have Been Related To 'Market Confusion Over Exclusivity Of Its Assets',2018-12-27 13:21:00-05:00,ZIOP,negative
1408229.0,Ziopharm Oncology Responds To Recent Stock Decline And Highlights Exclusivity Rights For Clinical Assets,2018-12-27 13:18:00-05:00,ZIOP,positive
1408230.0,"The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede",2018-12-27 07:51:00-05:00,ZIOP,neutral
1408231.0,"ZIOPHARM Oncology shares are trading up after the company announced a joint venture with TriArm Therapeutics to develop and commercialize 'Sleeping Beauty' CAR T therapies in China, Taiwan, and Korea.",2018-12-19 10:50:00-05:00,ZIOP,positive
1408232.0,22 Stocks Moving In Wednesday's Pre-Market Session,2018-12-19 08:07:00-05:00,ZIOP,neutral
1408233.0,"Ziopharm Reports Establishment Of Joint Venture With TriArm Therapeutics For Development, Commercialization Of Sleeping Beauty CAR T In China, Taiwan, Korea",2018-12-19 07:00:00-05:00,ZIOP,positive
1408234.0,"The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch",2018-12-14 07:47:00-05:00,ZIOP,neutral
1408235.0,Ziopharm Oncology Promotes Dr. David Mauney To President,2018-12-13 16:17:00-05:00,ZIOP,positive
1408236.0,35 Stocks Moving In Friday's Mid-Day Session,2018-11-23 12:25:00-05:00,ZIOP,neutral
1408237.0,Ziopharm shares up 13% on heavy volume following news of a raised stake to about 6.8% by MSD Partners.,2018-11-23 10:20:00-05:00,ZIOP,positive
1408238.0,"Ziopharm 13G Filing From MSD Partners Late Wed. Showed Raised Stake From ~3.4M Shares At End Of Last Qtr. To ~10.99M Shares, Or 6.8% Stake",2018-11-23 10:20:00-05:00,ZIOP,positive
1408239.0,Ziopharm Oncology Announces First Dosing Cohort Of OPDIVO Combination Trial Completed; Provides Other Updates And Data At Society For Neuro-Oncology,2018-11-16 14:33:00-05:00,ZIOP,neutral
1408240.0,"The Daily Biotech Pulse: Mallinckrodt FDA Verdict, European Cheer For Bristol-Myers Squibb, Morphosys Clinches Licensing Deal",2018-11-16 08:08:00-05:00,ZIOP,positive
1408241.0,64 Biggest Movers From Yesterday,2018-11-16 04:58:00-05:00,ZIOP,neutral
1408242.0,"Raymond James Upgrades ZIOPHARM Oncology to Outperform, Announces $5 Price Target",2018-11-15 14:24:00-05:00,ZIOP,neutral
1408243.0,55 Biggest Movers From Yesterday,2018-11-14 04:06:00-05:00,ZIOP,neutral
1408244.0,Ziopharm Oncology Announces Clinical Supply Agreement with Regeneron to Evaluate Combination Therapy for Patients with Brain Cancer,2018-11-12 07:18:00-05:00,ZIOP,negative
1408245.0,Ziopharm Oncology Announces Immuno-oncology Clinical Supply Agreement with Regeneron to Evaluate Combination Therapy for Patients with Brain Cancer,2018-11-12 07:14:00-05:00,ZIOP,negative
1408246.0,Zionpharm Announces $50M Private Placement for 19M Shares of Stock And 19M Warrants to Buy Shares at $3.01/Share,2018-11-12 06:59:00-05:00,ZIOP,positive
1408247.0,"Earnings Scheduled For November 12, 2018",2018-11-12 04:19:00-05:00,ZIOP,neutral
1408248.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-11 09:10:00-05:00,ZIOP,neutral
1408249.0,68 Stocks Moving In Friday's Mid-Day Session,2018-11-09 12:42:00-05:00,ZIOP,neutral
1408250.0,34 Stocks Moving In Friday's Pre-Market Session,2018-11-09 08:15:00-05:00,ZIOP,neutral
1408251.0,"Ziopharm Delays Q3 Earnings Report From Thurs., Nov. 8 To Mon., Nov. 12 Before Market Open",2018-11-08 16:29:00-05:00,ZIOP,neutral
1408252.0,60 Stocks Moving In Thursday's Mid-Day Session,2018-10-25 12:55:00-04:00,ZIOP,neutral
1408253.0,"The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price",2018-10-25 08:03:00-04:00,ZIOP,negative
1408254.0,"'6 kids dead, 12 sick in viral outbreak at New Jersey rehabilitation center' -ABC 7 NY",2018-10-23 15:00:00-04:00,ZIOP,negative
1408255.0,26 Stocks Moving In Tuesday's Pre-Market Session,2018-10-09 08:19:00-04:00,ZIOP,neutral
1408256.0,Ziopharm Oncology Announces New License Agreement With Intrexon Corporation; Agreement Will Provide Ziopharm With Certain Exclusive And Non-Exclusive Rights Ti Technology Controlled By Precogen,2018-10-09 07:03:00-04:00,ZIOP,positive
1408257.0,50 Biggest Movers From Yesterday,2018-08-23 05:10:00-04:00,ZIOP,neutral
1408258.0,"ZIOPHARM Oncology shares are trading up 6.3%, continuing to Rally following Wednesday's Q2 earnings report and trial updates.",2018-08-10 11:10:00-04:00,ZIOP,positive
1408259.0,77 Biggest Movers From Yesterday,2018-08-10 04:01:00-04:00,ZIOP,neutral
1408260.0,68 Stocks Moving In Thursday's Mid-Day Session,2018-08-09 12:41:00-04:00,ZIOP,neutral
1408261.0,ZIOPHARM Oncology shares are trading 16.7% higher to $2.93 after announcing quarterly earnings and releasing updates on multiple drug trials.,2018-08-09 10:35:00-04:00,ZIOP,positive
1408262.0,"ZIOPHARM Oncology Q2 EPS $(0.12), Inline",2018-08-08 16:58:00-04:00,ZIOP,neutral
1408263.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,ZIOP,positive
1408264.0,77 Biggest Movers From Yesterday,2018-08-08 06:04:00-04:00,ZIOP,neutral
1408265.0,"Stocks Which Set New 52-Week Low Yesterday, August 6th",2018-08-07 11:28:00-04:00,ZIOP,negative
1408266.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,ZIOP,negative
1408267.0,"Stocks Which Set New 52-Week Lows Friday, August 3rd",2018-08-06 13:20:00-04:00,ZIOP,negative
1408268.0,"Stocks Which Set New 52-Week Low Yesterday, July 30th",2018-07-31 09:25:00-04:00,ZIOP,negative
1408269.0,"Stocks Which Set New 52-Week Low Yesterday, July 26th:",2018-07-27 10:54:00-04:00,ZIOP,negative
1408270.0,"UPDATE: Ziopharm Director Scott Tarriff Says: 'Despite the recent request from the [FDA] for more information before allowing our phase 1 clinical trial to move forward, I remain excited about the future...we expect to provide additional guidance'",2018-07-26 13:06:00-04:00,ZIOP,positive
1408271.0,"UPDATE: Ziopharma Notes Annual Shareholder Meeting Moved Up 1 Day From Sept. 19, 2018 To Sept. 18, 2018",2018-07-26 12:12:00-04:00,ZIOP,neutral
1408272.0,"Ziopharm Oncology Board Responds To 'Recent Stock Price Decline' Says It Expects Add New Board Directors, Expand Management Team",2018-07-26 12:12:00-04:00,ZIOP,positive
1408273.0,"Stocks Which Set New 52-Week Lows Yesterday, July 24th:",2018-07-25 12:17:00-04:00,ZIOP,negative
1408274.0,"Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile",2018-07-25 08:41:00-04:00,ZIOP,positive
1408275.0,46 Biggest Movers From Yesterday,2018-07-25 04:03:00-04:00,ZIOP,neutral
1408276.0,34 Stocks Moving In Tuesday's Mid-Day Session,2018-07-24 12:28:00-04:00,ZIOP,neutral
1408277.0,Stocks Which Set New 52-Week Lows Yesterday:,2018-07-24 12:10:00-04:00,ZIOP,negative
1408278.0,"Benzinga's Daily Biotech Pulse: Celgene's Lymphoma Trial Meets Endpoint, Merit Medical's Strong Q2, Bluebird Bio Offering",2018-07-24 08:53:00-04:00,ZIOP,positive
1408279.0,Stocks Which Set New 52-Week Lows Friday,2018-07-23 11:11:00-04:00,ZIOP,negative
1408280.0,Ziopharm Oncology Enrolls Initial Patient in Phase 1 Trial Evaluating Combination Therapy of Controlled IL-12 and OPDIVO,2018-06-28 16:01:00-04:00,ZIOP,neutral
1408281.0,ZIOPHARM Oncology Option Alert: Oct 19 $4 Calls Sweep (38) near the Ask: 1598 @ $0.35 vs 1541 OI; Earnings 7/30 After Close [est] Ref=$3.0,2018-06-28 14:04:00-04:00,ZIOP,positive
1408282.0,"Benzinga's Daily Biotech Pulse: Epidiolex, Roche's Influenza Drug Gets Priority Review Status, Xeris Jumps On Positive Trial Results",2018-06-26 08:34:00-04:00,ZIOP,positive
1408283.0,"Benzinga's Daily Biotech Pulse: FDA Greenlights Tandem Diabetes' Insulin Pump, More IPOs On Tap",2018-06-22 08:51:00-04:00,ZIOP,neutral
1408284.0,60 Biggest Movers From Yesterday,2018-06-19 04:02:00-04:00,ZIOP,neutral
1408285.0,Mid-Afternoon Market Update: Crude Oil Up Over 1%; Gevo Shares Spike Higher,2018-06-18 14:38:00-04:00,ZIOP,negative
1408286.0,42 Stocks Moving In Monday's Mid-Day Session,2018-06-18 12:28:00-04:00,ZIOP,neutral
1408287.0,Mid-Day Market Update: Verastem Shares Climb On Duvelisib Data; ZIOPHARM Oncology Shares Slide,2018-06-18 12:16:00-04:00,ZIOP,positive
1408288.0,JP Morgan Downgrades ZIOPHARM Oncology to Underweight,2018-06-18 12:08:00-04:00,ZIOP,positive
1408289.0,Mid-Morning Market Update: Markets Open Lower; Vintage Capital To Acquire Rent-A-Center For $15/Share,2018-06-18 10:18:00-04:00,ZIOP,negative
1408290.0,Ziopharm Oncology Announces the FDA Put Clinical Hold on a Phase 1 Trial to Evaluate CD19-Specific CAR-T Therapies,2018-06-18 07:32:00-04:00,ZIOP,neutral
1408291.0,ZIOPHARM Oncology Option Alert: Jan 18 $5 Calls Sweep (21) above Ask!: 1000 @ $0.848 vs 10036 OI; Earnings 7/30 After Close [est] Ref=$4.31,2018-06-13 10:52:00-04:00,ZIOP,positive
1408292.0,Ziopharm Gives Update Data on IL-12 Into ASCO,2018-06-04 07:58:00-04:00,ZIOP,neutral
1408293.0,The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines,2018-06-03 19:27:00-04:00,ZIOP,negative
1408294.0,41 Biggest Movers From Yesterday,2018-05-31 04:45:00-04:00,ZIOP,neutral
1408295.0,"Benzinga's Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More",2018-05-17 08:27:00-04:00,ZIOP,neutral
1408296.0,38 Stocks Moving In Friday's Mid-Day Session,2018-05-11 12:28:00-04:00,ZIOP,neutral
1408297.0,"Benzinga's Daily Biotech Pulse: FDA Panel Nod For Akcea, Synergy's Revenue Miss, FDA Warns E-Liquid Makers Again",2018-05-11 08:21:00-04:00,ZIOP,negative
1408298.0,22 Stocks Moving In Friday's Pre-Market Session,2018-05-11 08:03:00-04:00,ZIOP,neutral
1408299.0,"'$ZIOP is ""pausing"" plans for its IL-12 gene therapy in recurrent brain tumor patients.'",2018-05-10 16:28:00-04:00,ZIOP,negative
1408300.0,"ZIOPHARM Oncology Q1 EPS $(0.15) Misses $(0.13) Estimate, Sales $146K Miss $1.5M Estimate",2018-05-10 16:27:00-04:00,ZIOP,negative
1408301.0,Exclusive: Ziopharm Oncology CEO Wants To Disrupt The CAR-T Supply Chain,2018-04-16 08:11:00-04:00,ZIOP,positive
1408302.0,Adam Feuerstein Tweets: My favorite part of $XON Q4 earnings release was part where RJ Kirk touts higher-than-expected revenue bc of an accounting treatment resulting from a failed GVHD program w/ $ZIOP.,2018-03-02 13:15:00-05:00,ZIOP,negative
1408303.0,"Ziopharm Oncology Reports Q4 EPS $(0.13) vs $(0.14) Est., Sales $1.60M vs $1.59M Est.",2018-03-01 16:09:00-05:00,ZIOP,neutral
1408304.0,Ziopharm Oncology Presents Data on Very Rapid Production of CAR T Cells at Keystone Symposia Emerging Cellular Therapies,2018-02-12 07:04:00-05:00,ZIOP,neutral
1408305.0,40 Biggest Movers From Yesterday,2018-02-07 05:09:00-05:00,ZIOP,neutral
1408306.0,Ziopharm Oncology Reaffirms FY18 Guidance,2018-02-06 08:56:00-05:00,ZIOP,neutral
1408307.0,"Ziopharm Oncology Issues Release Addressing 'Unfounded' Rumors, Stock Volatility: 'Management states that it knows of no developments at the Company that would be the cause of the recent volatility and decline in the stock price'",2018-02-06 08:56:00-05:00,ZIOP,negative
1408308.0,"Ziopharm Oncology Shares Weak On Potential Profit Taking, Down 7.2% On Heavy Volume; Monday Shares Were Up As Much As 23% On No News",2018-01-23 14:28:00-05:00,ZIOP,positive
1408309.0,38 Biggest Movers From Yesterday,2018-01-23 04:55:00-05:00,ZIOP,neutral
1408310.0,32 Stocks Moving In Monday's Mid-Day Session,2018-01-22 12:46:00-05:00,ZIOP,neutral
1408311.0,"STAT News' Adam F Tweets: '$ZIOP +22%. Put this in the ""stupid money has to flow somewhere"" bucket.'",2018-01-22 11:02:00-05:00,ZIOP,negative
1408312.0,ZIOPHARM Announces Presentation of Data from T-Cell Therapy Programs at #ASH2017,2017-12-10 17:41:00-05:00,ZIOP,neutral
1408313.0,28 Stocks Moving In Monday's Pre-Market Session,2017-11-20 08:06:00-05:00,ZIOP,neutral
1408314.0,ZIOPHARM Announces 'Positive' Updated Results of Ad-RTS-hIL-12 Study in Brain Cancer at Society for Neuro-Oncology Annual Meeting,2017-11-20 07:12:00-05:00,ZIOP,negative
1408315.0,"STAT News' Adam Feuerstein Tweets, Responds To Tweet On Ziopharm 'There is nothing positive about $ZIOP. On this, I am very certain.'",2017-11-07 15:16:00-05:00,ZIOP,negative
1408316.0,"ZIOPHARM Oncology Reports Q3 EPS $(0.13) vs $(0.14) Est., Collaboration Sales $1.598M vs $1.7M Est.",2017-11-06 16:49:00-05:00,ZIOP,neutral
1408317.0,9 Notable Biotechs Presenting At This Year's ASH Meeting,2017-11-06 16:31:00-05:00,ZIOP,neutral
1408318.0,"ZIOPHARM Shares Up 3% Premarket Ahead Of Q3 Earnings Report Aftermarket Monday; Earlier Announced Will Present 4 Abstracts At SNO, Including Update To Survival Data From Phase 1 Trial Of Ad-RTS-hIL-12 For Treatment Of GBM",2017-11-06 09:23:00-05:00,ZIOP,positive
1408319.0,ZIOPHARM Oncology Announces the First Patient Dosed in its Phase 1 Study of Ad-RTS-hiL-12,2017-10-16 07:05:00-04:00,ZIOP,neutral
1408320.0,ZIOPHARM Oncology Reports First Patient Dosed in New Phase 1 Study of Ad-RTS-hIL-12 plus Veledimex for the Treatment of Pediatric Brain Tumors,2017-10-16 07:00:00-04:00,ZIOP,neutral
1408321.0,Watch These 8 Huge Put Purchases In Friday Trade,2017-10-13 04:27:00-04:00,ZIOP,positive
1408322.0,Benzinga's Option Alert Recap From October 12,2017-10-12 16:33:00-04:00,ZIOP,positive
1408323.0,"Ziopharm Option Alert: Jan, 2019 $7 Puts Sweep (2) at the Ask: 500 @ $2.601 vs 69 OI; Ref=$5.69",2017-10-12 11:30:00-04:00,ZIOP,positive
1408324.0,"ZIOPHARM Reports Q2 EPS $(0.13), Inline, Collaboration Sales $1.597M vs $1.697M In Same Qtr. Last Year",2017-07-31 16:29:00-04:00,ZIOP,neutral
1408325.0,ZIOPHARM Oncology Reports Start of Stereotactic Treatment Cohort in Phase 1 Study of Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma,2017-06-28 07:00:00-04:00,ZIOP,neutral
1408326.0,12 Biggest Mid-Day Gainers For Thursday,2017-06-22 12:26:00-04:00,ZIOP,neutral
1408327.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-06-22 08:07:00-04:00,ZIOP,neutral
1408328.0,Mid-Afternoon Market Update: Fang Drops After Q1 Results; Invivo Therapeutics Shares Surge,2017-06-20 14:33:00-04:00,ZIOP,positive
1408329.0,ZIOPHARM Oncology Reports Median Overall Survival in Expanded 20 mg Cohort Maintained at 12.5 Months and Continues to Compare Favorably to Historical Controls; Impact of Steroids and Circulating Immune Cells Correlate with Immune Activation by IL-12,2017-06-05 14:15:00-04:00,ZIOP,positive
1408330.0,"Benzinga's Top Upgrades, Downgrades For June 1, 2017",2017-06-01 09:19:00-04:00,ZIOP,positive
1408331.0,"H.C. Wainwright Initiates Coverage On ZIOPHARM Oncology with Buy Rating, Announces $9.50 Price Target",2017-06-01 07:03:00-04:00,ZIOP,neutral
1408332.0,"Adam Feuerstein Tweet: $ZIOP selling 9.7M shares at $5.15, a 28% discount to market. Ouch.",2017-05-12 09:27:00-04:00,ZIOP,positive
1408333.0,"Adam Feuerstein Tweets: $ZIOP selling 9.7M shares at $5.15, a 28% discount to market. Ouch.",2017-05-12 09:27:00-04:00,ZIOP,positive
1408334.0,ZIOPHARM Oncology Reports Pricing of $50M Follow-On Offering of Common Stock,2017-05-12 09:22:00-04:00,ZIOP,neutral
1408335.0,ZIOPHARM Reports FDA Acceptance of IND for CD33-Specific CAR-T Cell Therapy Targeting Relapsed/Refractory Acute Myeloid Leukemia,2017-05-02 07:54:00-04:00,ZIOP,positive
1408336.0,"ZIOPHARM Oncology Reports Q1 EPS $(0.15) vs $(0.12) Est., Sales $1.597M vs $1.71M Est.",2017-05-01 16:34:00-04:00,ZIOP,neutral
1408337.0,Benzinga's Option Alert Recap From April 26,2017-04-26 16:54:00-04:00,ZIOP,positive
1408338.0,Option Alert: Ziopharm May 8.0 Calls Sweep: 837 @  ASK  $0.30: 2002 traded vs 4987 OI:  Earnings 5/1 After Close  $7.43 Ref,2017-04-26 14:22:00-04:00,ZIOP,positive
1408339.0,Option Alert: Ziopharm May 7.0 Calls Sweep: 1010 @  ASK  $0.599: 1315 traded vs 6088 OI:  Earnings 5/1 After Close  $7.23 Ref,2017-04-26 12:28:00-04:00,ZIOP,positive
1408340.0,Benzinga's Option Alert Recap From April 13,2017-04-13 16:49:00-04:00,ZIOP,positive
1408341.0,Option Alert: Ziopharm Jul 8.0 Calls Sweep: 1750 @  ASK  $0.75: 1752 traded vs 1749 OI:  Earnings 5/10 After Close [est]  $7.37 Ref,2017-04-13 12:18:00-04:00,ZIOP,positive
1408342.0,"Adam Feuerstein Tweets: Has anyone found the ""news"" in today's $ZIOP CAR-T PR? ""Update"" usually means something new, previously undisclosed. Not here.",2017-04-03 08:18:00-04:00,ZIOP,neutral
1408343.0,Option Alert: Ziopharm May 7.0 Calls Sweep: 1500 @  ASK  $0.40: 1500 traded vs 660 OI:  Earnings 5/10 After Close (est)  $6.35 Ref,2017-03-31 11:26:00-04:00,ZIOP,positive
1408344.0,Mid-Day Market Update: Dow Falls 80 Points; Cellect Biotechnology Shares Spike Higher,2017-03-27 12:15:00-04:00,ZIOP,positive
1408345.0,ZIOPHARM Calls Phase 2 Meeting With FDA Positive,2017-03-27 08:03:00-04:00,ZIOP,positive
1408346.0,Benzinga's Option Alert Recap From March 21,2017-03-21 16:45:00-04:00,ZIOP,positive
1408347.0,Option Alert: Ziopharm Jan18 8.0 Calls Sweep: 1686 @  ASK  $0.90: 1937 traded vs 2423 OI:  Earnings 5/10 After Close (est)  $5.94 Ref,2017-03-21 12:59:00-04:00,ZIOP,positive
1408348.0,Benzinga's Option Alert Recap From March 13,2017-03-14 06:50:00-04:00,ZIOP,positive
1408349.0,Option Alert: Ziopharm Apr 8.0 Calls Sweep: 500 @  ASK  $0.25: 2030 traded vs 4427 OI:  Earnings 5/10 After Close (est)  $6.67 Ref,2017-03-13 13:19:00-04:00,ZIOP,positive
1408350.0,Mid-Morning Market Update: Markets Mostly Lower; Intel To Buy Mobileye For $15 Billion,2017-03-13 10:03:00-04:00,ZIOP,negative
1408351.0,Benzinga's Option Alert Recap From February 23,2017-02-23 16:54:00-05:00,ZIOP,positive
1408352.0,Traders Attributing Spike Lower In ZIOPHARM To CEO Saying Co. There's A Pause In Beast Cancer Study In 2017 At RBC Conf.,2017-02-23 14:03:00-05:00,ZIOP,negative
1408353.0,Option Alert: Ziopharm Mar 7.0 Calls Sweep: 500 @  ASK  $0.40: 703 traded vs 2043 OI:  Earnings 5/10 After Close (est)  $6.77 Ref,2017-02-23 10:00:00-05:00,ZIOP,positive
1408354.0,"ZIOPHARM Oncology Reports Q4 EPS $(0.11) In-line, Sales $1.597M vs $1.7M Est.",2017-02-16 16:15:00-05:00,ZIOP,neutral
1408355.0,"Acacia, Exxon And Other Hot Stocks Among Short Sellers",2017-02-07 15:10:00-05:00,ZIOP,neutral
1408356.0,"6 Hot Stocks Among Shorts: IBM, Exxon Mobil And More",2017-01-31 13:38:00-05:00,ZIOP,neutral
1408357.0,The Street's Adam Feuerstein Tweets: Another PR hand-waving exercise from $ZIOP this morning demonstrates again their distance behind rivals in CAR-T.,2017-01-31 07:20:00-05:00,ZIOP,neutral
1408358.0,6 Hot Stocks Among Shorts: Weight Watchers Moves Ahead Of The Pack,2017-01-24 14:29:00-05:00,ZIOP,neutral
1408359.0,Option Alert: Ziopharm Apr 6.0 Calls Sweep: 573 @  ASK  $1.00: 598 traded vs 603 OI:  Earnings 2/28 After Close (est)  $5.47 Ref,2017-01-12 10:40:00-05:00,ZIOP,positive
1408360.0,Ziopharm Traders Got A Little Too Excited,2017-01-11 11:37:00-05:00,ZIOP,positive
1408361.0,"Watch For Downside In ZIOPHARM Shares, Adam Feuerstein Tweets: Let's be clear. FDA doesn't ""grant"" meetings w/ drug cos. Meetings w/ drug cos. is routine, even required, part of agency's job. $ZIOP",2017-01-11 11:07:00-05:00,ZIOP,positive
1408362.0,Adam Feuerstein @adamfeuerstein BREAKING: $ZIOP CEO tells #JPM17 audience FDA GRANTED THEM END OF PHASE 2 MEETING for Il-12 gene therapy.   Grounbreaking regulatory update,2017-01-11 10:47:00-05:00,ZIOP,positive
1408363.0,ZIOPHARM and Intrexon Announce Research and Development Agreement with the National Cancer Institute Utilizing Sleeping Beauty System to Generate T cells Targeting Neoantigens,2017-01-10 08:03:00-05:00,ZIOP,positive
1408364.0,"Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare Conference Presentation",2017-01-09 11:40:00-05:00,ZIOP,positive
1408365.0,Watch These 5 Huge Call Purchases In Tuesday Trade,2016-11-29 01:28:00-05:00,ZIOP,positive
1408366.0,Mid-Day Market Update: Crude Oil Up Over 2%; PhaseRx Shares Spike Higher,2016-11-28 12:08:00-05:00,ZIOP,negative
1408367.0,"Agora Financial Recommends To Buy Ziopharma, Calling For Short Squeeze; BZ NOTE: There is 38% Short Interest Currently",2016-11-28 10:35:00-05:00,ZIOP,positive
1408368.0,Option Alert: ZIOP Jan17 13.0 Calls Sweep: 614 @  ASK  $0.25: 994 traded vs 2897 OI:  Earnings 2/23 After Close (est)  $6.85 Ref,2016-11-28 10:35:00-05:00,ZIOP,positive
1408369.0,Mid-Afternoon Market Update: Marvell Gains On Earnings Beat;  Hibbett Shares Plummet,2016-11-18 14:37:00-05:00,ZIOP,positive
1408370.0,ZIOPHARM Announces Clinical Data On Brain Cancer Drug,2016-11-17 10:01:00-05:00,ZIOP,negative
1408371.0,ZIOPHARM Announces Clinical Data on Ad-RTS-hIL-12 Demonstrates Survival Benefits in Patients with Recurrent Brain Cancer,2016-11-17 07:06:00-05:00,ZIOP,negative
1408372.0,"ZIOPHARM Reports Q3 EPS $(0.11) vs. Est. $(0.11), Rev. $1.598M vs. Est. $1.49M",2016-11-09 17:14:00-05:00,ZIOP,neutral
1408373.0,Hearing ZIOPHARM Cancels Out Of Mizuho Healthcare Conf.,2016-10-25 13:46:00-04:00,ZIOP,negative
1408374.0,Mid-Afternoon Market Update: Crude Oil Down Over 2.5%; American Express Shares Gain On Earnings Beat,2016-10-20 15:08:00-04:00,ZIOP,positive
1408375.0,"ZIOPHARM Reports Data Showing Activation Of Anti-Tumor Immune Response Using Ad-RTS-hIL-12 In Patients With Breast Cancer, Shows ORR Was 11% At Week 12 As Of Aug. 30th",2016-10-10 07:05:00-04:00,ZIOP,negative
1408376.0,Watch These 5 Huge Put Purchases In Friday Trade,2016-09-09 01:37:00-04:00,ZIOP,positive
1408377.0,Option Alert: ZIOPHARM Oncology Fri $4 Puts at the bid: 5000 @ 0.201 vs. Open Interest 506,2016-09-08 13:26:00-04:00,ZIOP,positive
1408378.0,Mid-Afternoon Market Update: Guess? Jumps On Earnings Beat; Signet Jewelers Shares Tumble,2016-08-25 14:32:00-04:00,ZIOP,positive
1408379.0,Option Alert: ZIOPHARM Oncology Apr 21 $3 Calls Sweep at the bid: 1065 @ 2.9 vs. Open Interest 0,2016-08-24 14:03:00-04:00,ZIOP,positive
1408380.0,"Pre-Market Gainers Aug. 10, 2016: RTK Up 16.73%, VTVT 17.82%, YELP 12.68%, CBMX 9.59%, JD 9.52%, ASPS 5.43%, OXLC 6.80%, RL 6.45%, TOPS 4.51%, ZIOP 6.58%, EDIT 3.31%",2016-08-10 09:07:00-04:00,ZIOP,positive
1408381.0,Benzinga's Top Upgrades,2016-08-10 09:02:00-04:00,ZIOP,positive
1408382.0,Wells Fargo Upgrades ZIOPHARM Oncology to Market Perform,2016-08-10 07:07:00-04:00,ZIOP,positive
1408383.0,"ZIOPHARM Reports Q2 EPS $ (1.01) vs. Est. $(0.11), Rev. $1.69M vs. Est. $1.52M",2016-08-09 16:35:00-04:00,ZIOP,neutral
1408384.0,Ziopharm +8% Premarket @$5.40; Co Says Patient Death Unrelated to Brain Cancer Study,2016-07-19 08:08:00-04:00,ZIOP,negative
1408385.0,"UPDATE: ZIOPHARM Sees Reporting Data to FDA In Accordance with Study's Protocol, Applicable Regulations",2016-07-19 08:03:00-04:00,ZIOP,neutral
1408386.0,ZIOPHARM Offers Update on Phase I Study of Ad-RTS-hIL-12 in Brain Cancer: Patient Death Deemed Unrelated to Study Drug,2016-07-19 08:02:00-04:00,ZIOP,negative
1408387.0,10 Biggest Mid-Day Losers For Friday,2016-07-15 13:48:00-04:00,ZIOP,negative
1408388.0,Mid-Day Market Update: U.S. Stocks Turn Lower; Iteris Shares Climb Following Q1 Sales Outlook,2016-07-15 12:44:00-04:00,ZIOP,neutral
1408389.0,How Some ZIOP Buyers Got Screwed On Thursday Night,2016-07-15 12:41:00-04:00,ZIOP,negative
1408390.0,Technical Alert: ZIOPHARM Oncology Struggling To Remain A $5 Stock,2016-07-15 12:12:00-04:00,ZIOP,negative
1408391.0,Mid-Morning Market Update: Markets Open Higher; Wells Fargo Earnings Meet Estimates,2016-07-15 10:06:00-04:00,ZIOP,positive
1408392.0,UPDATE: Ziopharm Says Enrollment Remains Open in the Study,2016-07-15 09:30:00-04:00,ZIOP,neutral
1408393.0,UPDATE: Ziopharm Says Third Death Cause is Intracranial Hemorrhage,2016-07-15 09:29:00-04:00,ZIOP,negative
1408394.0,UPDATE: Ziopharm Says  First Two Patient Deaths were Unrelated to Study Drug,2016-07-15 09:28:00-04:00,ZIOP,neutral
1408395.0,ZIOPHARM Issues Statement Regarding Phase I Study of Gene Therapy Candidate Ad-RTS-hIL-12 in Brain Cancer,2016-07-15 09:27:00-04:00,ZIOP,negative
1408396.0,12 Stocks Moving In Friday's Pre-Market Session,2016-07-15 08:26:00-04:00,ZIOP,neutral
1408397.0,Ziopharm -10% Premarket @$5.09; Adam F Reported Brain Tumor Patient Death Following Gene Therapy Injection,2016-07-15 07:10:00-04:00,ZIOP,negative
1408398.0,Adam Feuerstein ‏@adamfeuerstein  Tweet: BREAKING --> Brain tumor patient dies after $ZIOP gene therapy Injection https://www.thestreet.com/story/13640891/1/brain-tumor-patient-dies-after-ziopharm-gene-therapy-injection.html … $XON,2016-07-14 21:46:00-04:00,ZIOP,negative
1408399.0,UPDATE: ZIOPHARM Shares Down 14% Following Concerning Adam Feuerstein Tweet on Co. Offering,2016-07-14 16:47:00-04:00,ZIOP,positive
1408400.0,ZIOPHARM Oncology Shares Trading Down 12.5% At $4.91/Share,2016-07-14 16:43:00-04:00,ZIOP,positive
1408401.0,"Adam Feuerstein Tweets: $ZIOP was trying to raise $40-50M thru Jefferies over past couple of days. Deal was abandoned this afternoon, according to a source.",2016-07-14 16:35:00-04:00,ZIOP,negative
1408402.0,Watch These 7 Huge Call Purchases In Thursday Trade,2016-07-14 04:22:00-04:00,ZIOP,positive
1408403.0,Option Alert: ZIOP Aug16 8.0 Calls Sweep: 536 @  ASK  $0.35: 737 traded vs 8695 OI:  Earnings 8/8  $5.66 Ref,2016-07-13 15:19:00-04:00,ZIOP,positive
1408404.0,"ZIOPHARM Reports Plans for Phase I Clinical Trial with CD33 CAR-T Cell Therapy Targeting Acute Myeloid Leukemia, Note Last Thursday CAR-T Names Fell On Juno Report Of 2 Patient Deaths",2016-07-12 09:06:00-04:00,ZIOP,neutral
1408405.0,This Analyst Just Tripled Intrexon's Zika Drug Sales Estimates,2016-07-07 08:33:00-04:00,ZIOP,neutral
1408406.0,Watch These 7 Huge Call Purchases In Friday Trade,2016-07-01 02:46:00-04:00,ZIOP,positive
1408407.0,Option Alert: ZIOP Aug16 8.0 Calls: 3000 @  ASK  $0.35: 5000 traded vs 1021 OI:  Earnings 8/8  $5.61 Ref,2016-06-30 09:41:00-04:00,ZIOP,positive
1408408.0,"Adam Feuerstein @adamfeuerstein Tweet: $XON trades 30% of $ZIOP royalties for $120M in preferred shares, which implies NPV of their program is only $400M. Terrible for $ZIOP.",2016-06-30 08:51:00-04:00,ZIOP,negative
1408409.0,"21Vianet Group, Ziopharm, Starz to Resume at 8:30 AM ET",2016-06-30 08:10:00-04:00,ZIOP,neutral
1408410.0,"Intrexon, ZIOPHARM Report Amendment to Exclusive Channel Collaborations to Improve Alignment as Programs Advance Through Development",2016-06-30 08:01:00-04:00,ZIOP,positive
1408411.0,ZIOPHARM Shares Halted News Pending,2016-06-30 07:58:00-04:00,ZIOP,positive
1408412.0,Option Alert: ZIOP Oct16 6.0 Calls: 1800 @  ASK  $1.55: 1823 traded vs 5751 OI:  Earnings 8/8  $6.01 Ref,2016-06-22 13:59:00-04:00,ZIOP,positive
1408413.0,Option Alert: ZIOP Oct16 6.0 Calls: 5000 @  ASK  $1.60: 5022 traded vs 719 OI:  Earnings 8/8  $6.09 Ref,2016-06-14 10:42:00-04:00,ZIOP,positive
1408414.0,Option Alert: ZIOP Jul16 10.0 Calls Sweep: 1002 @  ASK  $0.25: 1004 traded vs 9884 OI: $7.49 Ref,2016-06-07 10:51:00-04:00,ZIOP,positive
1408415.0,Raymond James Initiates Coverage on ZIOPHARM Oncology at Market Perform,2016-06-02 08:22:00-04:00,ZIOP,neutral
1408416.0,15 Stocks Moving In Thursday's Pre-Market Session,2016-05-19 08:16:00-04:00,ZIOP,neutral
1408417.0,ZIOPHARM Offers Data Highlighting Favorable Interim Survival Results with Ad-RTS-hIL-12 in Brain Cancer,2016-05-18 17:04:00-04:00,ZIOP,negative
1408418.0,Option Alert: ZIOP May16 10.0 Calls Sweep: 500 @  ASK  $0.15: 550 traded vs 4572 OI: $8.27 Ref,2016-05-11 11:55:00-04:00,ZIOP,positive
1408419.0,"ZIOPHARM Oncology Shares Spikes To $7.90, Company Reported Earnings Yesterday",2016-05-11 11:49:00-04:00,ZIOP,positive
1408420.0,"ZIOPHARM Oncology Reports Q1 EPS $(0.09) vs. Est. $(0.08), Rev. $1.969M vs. Est. $1.49M",2016-05-10 17:04:00-04:00,ZIOP,neutral
1408421.0,Option Alert: ZIOP Jul16 10.0 Calls Sweep: 2001 @  ASK  $0.85: 2292 traded vs 6671 OI:  Earnings 5/5  $7.94 Ref,2016-04-22 12:03:00-04:00,ZIOP,positive
1408422.0,Option Alert: ZIOP Jun16 12.0 Calls Sweep: 660 @  ASK  $0.40: 2900 traded vs 585 OI:  Earnings 5/5  $9.02 Ref,2016-04-19 15:34:00-04:00,ZIOP,positive
1408423.0,Option Alert: ZIOP Jun16 12.0 Calls Sweep: 500 @  ASK  $0.50: 1006 traded vs 585 OI:  Earnings 5/5  $9.13 Ref,2016-04-19 11:31:00-04:00,ZIOP,positive
1408424.0,Option Alert: ZIOP Jun16 11.0 Calls: 3717 @  ASK  $0.70: 5187 traded vs 208 OI:  Earnings 5/5  $8.96 Ref,2016-04-19 11:07:00-04:00,ZIOP,positive
1408425.0,Option Alert: ZIOP Jun16 11.0 Calls Sweep: 1000 @  ASK  $0.55: 1050 traded vs 208 OI:  Earnings 5/5  $8.85 Ref,2016-04-19 10:59:00-04:00,ZIOP,positive
1408426.0,ZIOPHARM Announces Two Oral Presentations at ASGCT,2016-04-18 12:41:00-04:00,ZIOP,neutral
1408427.0,Solasia Initiates Phase 2 Study of Darinaparsin (SP-02) for Peripheral T-Cell Lymphoma Under License from Ziopharm,2016-03-28 04:27:00-04:00,ZIOP,neutral
1408428.0,"6 Stocks Trending In Short-Selling Circles: Seadrill, Tesla, Weight Watchers And More",2016-03-15 16:53:00-04:00,ZIOP,neutral
1408429.0,Ziopharm Announces Molecular Therapy Publication Highlights Sleeping Beauty Potential in Personalized TCR Gene Therapy,2016-03-09 08:16:00-05:00,ZIOP,positive
1408430.0,Ziopharm Sells Off to Low of $8.50,2016-03-04 15:44:00-05:00,ZIOP,negative
1408431.0,Option Alert: ZIOP Mar16 9.0 Puts Sweep: 1150 @  ASK  $0.95: 2198 traded vs 513 OI: $8.70 Ref,2016-03-04 15:44:00-05:00,ZIOP,positive
1408432.0,"ZIOPHARM Shares Stage Last-10-Min Rally, Up ~3.7% Over Last Few Mins; Up 6.7% to $8.39 for Intraday Session",2016-03-01 15:56:00-05:00,ZIOP,positive
1408433.0,Option Alert: ZIOP Mar16 12.0 Calls Sweep: 500 @  ASK  $0.10: 609 traded vs 5193 OI: $7.89 Ref,2016-02-26 14:19:00-05:00,ZIOP,positive
1408434.0,Option Alert: ZIOP Mar16 12.0 Calls Sweep: 500 @  ASK  $0.10: 4523 traded vs 840 OI:  Earnings today  $7.64 Ref,2016-02-25 11:55:00-05:00,ZIOP,positive
1408435.0,Option Alert: ZIOP Mar16 12.0 Calls: 700 @  ASK  $0.05: 700 traded vs 840 OI:  Earnings today  $8.00 Ref,2016-02-25 09:32:00-05:00,ZIOP,positive
1408436.0,"ZIOPHARM Reports Q4 EPS $(0.07) vs. Est. $(0.07), Rev. $1.9M vs. Est. $1.74M",2016-02-24 16:57:00-05:00,ZIOP,neutral
1408437.0,ZIOPHARM Reports First Patient Treated in Dose Escalation Portion of Phase 1 Trial of Ad-RTS-hIL-12 for Advanced Glioma,2016-02-24 07:04:00-05:00,ZIOP,positive
1408438.0,Option Alert: ZIOP Mar16 7.0 Calls Sweep: 504 @  ASK  $1.10: 1606 traded vs 7295 OI:  Earnings 2/25  $7.19 Ref,2016-02-23 15:34:00-05:00,ZIOP,positive
1408439.0,Option Alert: ZIOP Feb16 6.0 Calls Sweep: 1413 @  ASK  $0.35: 2056 traded vs 2475 OI:  Earnings 2/25  $6.11 Ref,2016-02-16 15:54:00-05:00,ZIOP,positive
1408440.0,"Ziopharm Oncology Shares Spike Above $6.00, HOD $6.06",2016-02-16 15:45:00-05:00,ZIOP,positive
1408441.0,CORRECTION: 13F from Third Point Showed No Stake in Ziopharm; Was Not A New Stake,2016-02-12 16:23:00-05:00,ZIOP,negative
1408442.0,Option Alert: ZIOP Mar16 10.0 Calls: 1376 @  ASK  $0.20: 1617 traded vs 0 OI:  Earnings 2/25  $5.08 Ref,2016-02-09 13:56:00-05:00,ZIOP,positive
1408443.0,Option Alert: ZIOP Apr16 6.0 Calls Sweep: 1324 @  ASK  $1.05: 1568 traded vs 517 OI:  Earnings 2/25  $5.03 Ref,2016-02-09 09:46:00-05:00,ZIOP,positive
1408444.0,Option Alert: ZIOP Mar16 6.0 Calls Sweep: 1919 @  ASK  $0.70: 1944 traded vs 770 OI:  Earnings 2/25  $4.84 Ref,2016-02-09 09:43:00-05:00,ZIOP,positive
1408445.0,Option Alert: ZIOP Mar16 8.0 Calls Sweep: 2595 @  ASK  $0.20: 2595 traded vs 1053 OI:  Earnings 2/25  $4.71 Ref,2016-02-09 09:42:00-05:00,ZIOP,positive
1408446.0,This Week Is Paramount For Biotech Stocks,2016-01-11 13:10:00-05:00,ZIOP,neutral
1408447.0,Option Alert: ZIOP Jan16 12.0 Calls Sweep: 681 @  ASK  $0.10: 681 traded vs 11k OI: $8.32 Ref,2015-12-31 12:09:00-05:00,ZIOP,positive
1408448.0,Mid-Day Market Update: Crude Oil Drops Over 3%; Sunedison Shares Spike Higher,2015-12-30 12:15:00-05:00,ZIOP,negative
1408449.0,Ziopharm Spikes to High on Volume,2015-12-30 11:07:00-05:00,ZIOP,neutral
1408450.0,Option Alert: ZIOP Jan16 10.0 Calls Sweep: 1000 @  ASK  $0.35: 1093 traded vs 20k OI: $8.44 Ref,2015-12-30 11:05:00-05:00,ZIOP,positive
1408451.0,EXCLUSIVE With Ziopharm CEO: Here's Why Our Genetic Programming Is Different From Competitors,2015-12-18 11:59:00-05:00,ZIOP,positive
1408452.0,Ziopharm CEO Says Co. To Have 'Exciting Data At ASCO' On Its Viral Program Mid-Year,2015-12-18 11:57:00-05:00,ZIOP,positive
1408453.0,Ziopharm CEO Says Focus On Genetic Programming Sets Company Apart From Other T-Cell Researchers,2015-12-18 10:56:00-05:00,ZIOP,neutral
1408454.0,"Zipharma recovers from two-month low, struggles to clear Thusrday's close ($9.65)",2015-12-11 11:49:00-05:00,ZIOP,negative
1408455.0,"Shares of ZIOPHARM Spike Over $9.40 Over Last Few Mins, Up ~$0.50 to $9.49",2015-12-11 11:01:00-05:00,ZIOP,positive
1408456.0,Option Alert: ZIOP Jan16 10.0 Calls Sweep: 1000 @  ASK  $0.80: 1040 traded vs 15k OI: $9.33 Ref,2015-12-11 11:00:00-05:00,ZIOP,positive
1408457.0,ZIOPHARM Reports Presentation of Phase 1b/2 Study of Ad-RTS-hIL-12 Gene Therapy in Patients With Locally Advanced or Metastatic Breast Cancer at 2015 SABCS,2015-12-10 07:00:00-05:00,ZIOP,negative
1408458.0,Mid-Morning Market Update: Markets Tumble; AutoZone Profit Tops Estimates,2015-12-08 10:14:00-05:00,ZIOP,positive
1408459.0,Ziopharm Oncology Shares Trade Up After Hours After 8-K Shows CD19-specific CAR T-cell therapy Update,2015-12-07 18:04:00-05:00,ZIOP,positive
1408460.0,Wells Fargo Initiates Coverage on ZIOPHARM Oncology at Underperform,2015-12-04 07:56:00-05:00,ZIOP,positive
1408461.0,Option Alert: $ZIOP Dec $14.0 Call Sweep; 2977 Contracts @Ask $0.80; Ref $12.77,2015-11-23 09:50:00-05:00,ZIOP,positive
1408462.0,Option Alert: $ZIOP Dec $14 Call Sweep; 1206 Contracts above Ask @$1.43; Ref $13.14,2015-11-19 09:41:00-05:00,ZIOP,positive
1408463.0,ZIOPHARM Reports Data Highlighting Ad-RTS-hIL-12 Activity in Glioma at SNO,2015-11-19 07:06:00-05:00,ZIOP,neutral
1408464.0,Option Alert: $ZIOP Nov $14 Call Sweep; 1457 Contracts @Ask @$0.20; Ref $12.38,2015-11-17 14:48:00-05:00,ZIOP,positive
1408465.0,Stocks Hitting 52-Week Highs,2015-11-10 10:34:00-05:00,ZIOP,neutral
1408466.0,"ZIOPHARM Reports Q3 EPS $(0.14) vs. Est. $(0.12), Rev. $1.869M vs. Est. $1.62M",2015-11-02 16:10:00-05:00,ZIOP,neutral
1408467.0,EDIT: ZIOPHARM Reports Q3 Loss $0.14 vs Est Loss $0.21,2015-11-02 16:06:00-05:00,ZIOP,negative
1408468.0,"Shares of ZIOPHARM Plunge Well Into Negative Territory, Now Down 4.2% for Session",2015-10-30 11:19:00-04:00,ZIOP,negative
1408469.0,Short Selling: Karl Loomes Picks The Six Hottest U.S.-Listed Stocks,2015-10-08 15:35:00-04:00,ZIOP,neutral
1408470.0,6 U.S.-Listed Stocks Short Sellers Are Strongly Betting Against,2015-09-30 15:15:00-04:00,ZIOP,positive
1408471.0,The Approaching 'Vast Opportunity' For Intrexon,2015-09-30 11:12:00-04:00,ZIOP,positive
1408472.0,Intrexon and ZIOPHARM to Develop Immunotherapies for Treatment of Graft-Versus-Host Disease,2015-09-28 16:00:00-04:00,ZIOP,neutral
1408473.0,ZIOPHARM Announces Cancer Research Publication of Study Demonstrating Preferential Targeting of Solid Tumor Cells by Modified CAR T Cells,2015-09-01 08:00:00-04:00,ZIOP,negative
1408474.0,10 Biotech Stocks With Catalysts Coming Soon,2015-08-20 12:19:00-04:00,ZIOP,neutral
1408475.0,13F from Loeb's Third Point Shows Ziopharm Oncology Shows New 1.95M Share Stake,2015-08-14 16:23:00-04:00,ZIOP,positive
1408476.0,Ziopharm Moving; May be Attributed to Article in EurekAlet 'Researchers develop advanced cell screening technology for cancer immunotherapy ',2015-08-10 10:38:00-04:00,ZIOP,negative
1408477.0,ZIOPHARM Reports Orphan Drug Designation for Ad-RTS-hIL-12 in the Treatment of Malignant Glioma,2015-07-24 11:17:00-04:00,ZIOP,neutral
1408478.0,Ziopharm Shares Spike Higher,2015-06-29 16:15:00-04:00,ZIOP,positive
1408480.0,Ziopharm Oncology Downgraded By BMO As 'Questions Persist',2015-06-22 09:30:00-04:00,ZIOP,neutral
1408481.0,"BMO Capital Downgrades ZIOPHARM Oncology to Market Perform, Lowers PT to $10.00",2015-06-22 06:31:00-04:00,ZIOP,negative
1408482.0,Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares,2015-06-05 08:05:00-04:00,ZIOP,positive
1408483.0,Juno Shares Falling; May be Attributed to Bloomberg Correcting Earlier Story of AstraZeneca CEO Saying Would Buy Co Such as Juno,2015-06-02 13:47:00-04:00,ZIOP,positive
1408484.0,AstraZeneca CEO Soriot Said CAR T Therapy Candidates Would Need to Be Able to Manage Side Effects Before Co. Would Be Interested in Deal,2015-06-02 10:30:00-04:00,ZIOP,positive
1408485.0,"Shares of Ziopharm, Juno Moving Higher; Note Being Circulated Says Juno, Ziopharm Potential Targets of AstraZeneca",2015-06-02 10:23:00-04:00,ZIOP,positive
1408486.0,"ZIOPHARM Announces Caesar J. Belbel, Chief Legal Officer, Appointed COO",2015-06-02 07:04:00-04:00,ZIOP,positive
1408487.0,Guggenheim Securities Initiates Coverage on ZIOPHARM Oncology at Neutral,2015-05-13 06:12:00-04:00,ZIOP,positive
1408488.0,Intrexon Declares Special Stock Dividend of 17.8M Shares of Ziopharm,2015-05-11 16:20:00-04:00,ZIOP,positive
1408489.0,US Stock Futures Slide Ahead Of Jobless Claims,2015-05-07 07:22:00-04:00,ZIOP,neutral
1408490.0,"ZIOPHARM names Laurence J. N. Cooper, M.D., Ph.D., CEO",2015-05-07 07:03:00-04:00,ZIOP,neutral
1408491.0,Option Alert: Ziopharm May $10 Call; 2000 Contract Trade at Ask @$0.805; Now $9.75,2015-05-06 10:25:00-04:00,ZIOP,positive
1408492.0,Ziopharm Spikes Higher,2015-05-06 10:24:00-04:00,ZIOP,neutral
1408494.0,ZIOPHARM Reports Initiation of Phase 1 Study of Ad-RTS-IL-12 Gene Therapy for Patients with Brain Cancer,2015-05-05 07:19:00-04:00,ZIOP,negative
1408496.0,Option Alert: Ziopharm Jun $11 Call; 1250 Contract Trade at Ask @$1.00,2015-04-29 11:14:00-04:00,ZIOP,positive
1408497.0,ZIOPHARM Begins Phase 1b/2 Study of Ad-RTS-hIL-12 Gene Therapy in Patients With Locally Advanced or Metastatic Breast Cancer,2015-04-27 08:02:00-04:00,ZIOP,negative
1408498.0,CAR-T Therapy Stocks Hit Hard Following AACR Data,2015-04-20 13:44:00-04:00,ZIOP,negative
1408499.0,It's A Big Weekend For Biotech,2015-04-17 16:31:00-04:00,ZIOP,neutral
1408502.0,Option Alert: Ziopharm Apr $11 Call; 1000 Contract Trade at Ask @$0.30,2015-04-13 11:18:00-04:00,ZIOP,positive
1408503.0,Biotech Bubble Valuations From Sam Islay,2015-04-02 07:13:00-04:00,ZIOP,neutral
1408504.0,Ziopharm Spiking on CNBC/Miller Mention,2015-03-27 12:28:00-04:00,ZIOP,neutral
1408505.0,5 High-Potential Stocks This Technician Is Watching,2015-03-21 11:29:00-04:00,ZIOP,neutral
1408506.0,Option Alert: Ziopharm Apr $17 Call; 4393 Contracts Traded vs 1547 OI Now $14.28,2015-03-19 12:42:00-04:00,ZIOP,positive
1408507.0,Mizuho Securities Downgrades ZIOPHARM Oncology to Neutral on Valuation,2015-03-10 04:48:00-04:00,ZIOP,positive
1408508.0,Ziopharm Spikes Higher on Volume,2015-03-03 14:01:00-05:00,ZIOP,neutral
1408509.0,"Earning & Economic Calendar for Tuesday March 3, 2015",2015-03-03 05:19:00-05:00,ZIOP,neutral
1408510.0,"Mizuho Securities Maintains Buy on ZIOPHARM Oncology, Raises PT to $14.00",2015-03-02 07:29:00-05:00,ZIOP,positive
1408512.0,Option Alert: Ziopharm Apr $15 Call; 1883 Contracts Traded at Ask @$1.20; Now $11.31,2015-02-27 15:13:00-05:00,ZIOP,positive
1408513.0,Friday's #PreMarket Movers: JC Penney Down Following Q4 Earnings,2015-02-27 09:32:00-05:00,ZIOP,neutral
1408514.0,"Ziopharm Reports Q4 EPS $(0.09) vs. $(0.14), Rev. $340K vs. $420K",2015-02-26 17:15:00-05:00,ZIOP,neutral
1408515.0,Biotech Stocks Moving Higher,2015-02-23 15:35:00-05:00,ZIOP,neutral
1408516.0,Fast Money Halftime Report Final Trade From February 23,2015-02-23 15:27:00-05:00,ZIOP,neutral
1408517.0,Option Alert: Ziopharm Mar $10 Call; 5188 Contracts Traded vs 152 OI; Now $9.99,2015-02-23 10:08:00-05:00,ZIOP,positive
1408519.0,"Notable Option Activity For February 12: ZIOP, VIPS, BA, KO, CSCO, CMCSA",2015-02-12 15:40:00-05:00,ZIOP,neutral
1408521.0,"Ziopharm Oncology Director Kirk Buys 1,440,000 Shares @$8.75/Share -Form 4",2015-02-10 15:51:00-05:00,ZIOP,positive
1408522.0,"Ziopharm Oncology 13D Filing Shows Randal Kirk Holds 16.9% Stake, Up From 0.07% Reported Dec 31 2013",2015-02-10 15:00:00-05:00,ZIOP,neutral
1408523.0,ZIOPHARM Prices 10M Share Offering @$8.75/Share,2015-02-03 18:35:00-05:00,ZIOP,positive
1408524.0,ZIOPHARM Prices 10M Shares at $8.75/Share,2015-02-03 18:33:00-05:00,ZIOP,positive
1408525.0,Mid-Morning Market Update: Markets Open Higher; AutoNation Profit Beats Views,2015-02-03 10:55:00-05:00,ZIOP,positive
1408526.0,The 3 Best Biotech Stocks Of The Last 30 Days,2015-02-02 21:50:00-05:00,ZIOP,positive
1408527.0,Ziopharm to Commence Public Offering of $75M Worth of Common Stock,2015-02-02 16:17:00-05:00,ZIOP,positive
1408528.0,"Najarian Says Exelixis Could be Next Ziopharm, Intrexon-type Runner, Based on Call Activity",2015-01-28 10:48:00-05:00,ZIOP,neutral
1408529.0,Option Alert: Ziopharm Feb $11 Call; 5765 Contracts Traded vs 410 OI; Now $8.43,2015-01-27 10:40:00-05:00,ZIOP,positive
1408530.0,Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity Shares Spike Higher,2015-01-21 15:10:00-05:00,ZIOP,positive
1408531.0,4 More Biotech Secondaries Traders Are Watching,2015-01-21 13:38:00-05:00,ZIOP,neutral
1408532.0,"Solasia Pharma, Meiji Seika Pharma Announce License, Collaboration Agreement for Darinaparsin",2015-01-19 07:16:00-05:00,ZIOP,positive
1408533.0,TheStreetSweeper releases its new report on Ziopharm Oncology (ZIOP),2015-01-16 10:12:00-05:00,ZIOP,neutral
1408534.0,10 Biotech Stories You Might've Missed This Week,2015-01-15 13:18:00-05:00,ZIOP,negative
1408535.0,Mid-Morning Market Update: Markets Drop; JPMorgan Posts Lower Earnings,2015-01-14 10:53:00-05:00,ZIOP,negative
1408536.0,Stocks Hitting 52-Week Highs,2015-01-14 10:18:00-05:00,ZIOP,neutral
1408537.0,Morning Market Gainers,2015-01-14 09:41:00-05:00,ZIOP,neutral
1408538.0,Wednesday Morning Movers: Tesla Continues To Drop,2015-01-14 08:58:00-05:00,ZIOP,negative
1408539.0,Benzinga's Top #PreMarket Gainers,2015-01-14 08:06:00-05:00,ZIOP,positive
1408540.0,Ziopharm Shares Rise 55% Premarket Following Announcement of Licensing Agreement with University of Texas MD Anderson Cancer Center,2015-01-14 07:28:00-05:00,ZIOP,neutral
1408541.0,"BMO Capital Upgrades ZIOPHARM Oncology to Outperform, Raises PT to $15.00",2015-01-14 06:20:00-05:00,ZIOP,neutral
1408542.0,"Shares of ZIOPHARM Resume, Now Up ~13%",2015-01-13 16:57:00-05:00,ZIOP,positive
1408543.0,Shares of ZIOPHARM to Resume Trade at 4:55 p.m. EST,2015-01-13 16:34:00-05:00,ZIOP,positive
1408544.0,"UPDATE: Intrexon, ZIOPHARM, MD Anderson Report Exclusive CAR T Deal",2015-01-13 16:27:00-05:00,ZIOP,positive
1408545.0,"Shares of ZIOPHARM Halted Following News Intrexon, Co., MD Anderson Have Reported Exclusive CAR T Deal",2015-01-13 16:26:00-05:00,ZIOP,positive
1408546.0,Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3,2015-01-13 10:58:00-05:00,ZIOP,neutral
1408547.0,"ZIOPHARM, Intrexon Offer Clinical, Preclinical Data from Immuno-Oncology Programs: Showed Anti-Cancer Activity, Planning Phase 1b/@ Trial AD-RTS-HIL-12 with Veledimex",2014-12-03 12:36:00-05:00,ZIOP,neutral
1408548.0,ZIOPHARM Oncology Inc Reports Q3 EPS of $(0.06) vs $(0.12) Est; Revenue of $633.0K vs $3.43M Est,2014-10-30 16:25:00-04:00,ZIOP,neutral
1408549.0,Mid-Afternoon Market Update: Dow Rises Over 150 Points; Kohl's Shares Decline On Weak Forecast,2014-10-28 15:39:00-04:00,ZIOP,negative
1408550.0,"Option Alert: Ziopharm Dec $4 Call; 5,457 Contracts Traded vs 2 OI; Currently $2.78",2014-10-23 12:28:00-04:00,ZIOP,positive
1408551.0,Ziopharm Q2 EPS -$0.06 Vs -$0.13,2014-08-07 16:05:00-04:00,ZIOP,neutral
1408552.0,"ZIOPHARM Oncology, Solasia Pharma Announce Global License and Collaboration Agreement for Darinaparsin ",2014-07-31 16:18:00-04:00,ZIOP,positive
1408553.0,ZIOPHARM Announces Expansion Of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon And Clinical Program Update,2014-07-22 07:02:00-04:00,ZIOP,neutral
1408554.0,Mid-Morning Market Update: Markets Gain On Jobs Data; VeriFone Earnings Beat Estimates,2014-06-06 10:25:00-04:00,ZIOP,positive
1408555.0,"Morning Market Movers Friday, May 23, 2014",2014-05-23 10:44:00-04:00,ZIOP,neutral
1408556.0,UPDATE: ZIOPHARM Results of Ad-RTS-IL-12 Correlated with Reducing Cancer Stem Cells in Brain,2014-05-22 16:21:00-04:00,ZIOP,negative
1408557.0,Ziopharm Announces Announced Positive Results of Ad-RTS-IL-12,2014-05-22 16:16:00-04:00,ZIOP,positive
1408558.0,"ZIOPHARM Oncology Inc Reports Q1 EPS of $(0.10), Inline",2014-05-08 16:04:00-04:00,ZIOP,neutral
1408559.0,ZIOPHARM Presents Preclinical Data at AACR Annual Meeting Supporting Controlled DNA-based IL-12 Therapy for Brain Cancer,2014-04-08 11:01:00-04:00,ZIOP,negative
1408560.0,ZIOPHARM Shares Push Over $4.50 Level Following Report of Piper Jaffray Mid-Day Upgrade,2014-03-04 10:38:00-05:00,ZIOP,positive
1408561.0,ZIOPHARM Oncology Inc Reports Q4 EPS of $(0.09) vs $(0.15) Est; Revenue of $200.0K vs $200.0K Est,2014-03-03 16:39:00-05:00,ZIOP,neutral
1408562.0,ZIOPHARM Announces Positive Phase 1/2 Interim Results for Ad-RTS-IL-12 in Patients With Advanced Melanoma ,2013-12-07 09:24:00-05:00,ZIOP,positive
1408563.0,"Option Alert: Ziopharm December 5 Call; 2,949 Contract Trade Between Bid and Ask @$0.17; Currently $3.96",2013-12-06 15:48:00-05:00,ZIOP,positive
1408564.0,ZIOPHARM Announces Unanimous Recombinant DNA Advisory Committee (RAC) Approval for Phase 1 Study of Ad-RTS-IL-12 in Subjects With Recurrent or Progressive Glioblastoma ,2013-12-06 07:01:00-05:00,ZIOP,positive
1408565.0,Ziopharm Spikes to High,2013-12-03 15:40:00-05:00,ZIOP,neutral
1408566.0,"Option Alert: Ziopharm December 5 Call; 3,510 Contract Trade Between Bid and Ask @$0.13; Currently $3.74",2013-11-25 12:11:00-05:00,ZIOP,positive
1408567.0,Amended 13D Filing from Kirk Randal on Ziopharm Shows 18.2% Stake,2013-10-31 15:14:00-04:00,ZIOP,neutral
1408568.0,Ziopharm Prices 14.3M Shares at $3.50/Share,2013-10-24 07:05:00-04:00,ZIOP,positive
1408569.0,ZIOPHARM Announces $50M Offering of Common Stock ,2013-10-22 16:05:00-04:00,ZIOP,neutral
1408570.0,"Shares of Ziopharm, Intrexon Quiet Following Presentation Showing HIL-12 is Fully Functional in Study Assay",2013-10-22 12:43:00-04:00,ZIOP,positive
1408571.0,ZIOPHARM Oncology Inc Reports Q2 EPS of $(0.22) Which May Not Compare $(0.24) Est,2013-08-08 16:08:00-04:00,ZIOP,neutral
1408572.0,Ziopharm Spikes Higher,2013-06-26 14:54:00-04:00,ZIOP,neutral
1408573.0,Afternoon Market Losers,2013-06-12 14:10:00-04:00,ZIOP,negative
1408574.0,The Battle of IL-12 Administration For Cancer Treatment: Is It Really A Battle?,2013-06-06 14:40:00-04:00,ZIOP,negative
1408575.0,ZIOPHARM Presents Updated Results from Phase 1 Ad-RTS-IL-12 Study in Advanced Melanoma at ASCO,2013-06-01 14:34:00-04:00,ZIOP,positive
1408576.0,Morning Market Losers,2013-05-28 10:18:00-04:00,ZIOP,negative
1408577.0,Ziopharm IR Spokesperson Says No Company News Related to Unusual Option Activity; Will be Presenting May 29 at Deutsche Bank Health Care Conference ,2013-05-23 16:56:00-04:00,ZIOP,positive
1408578.0,"Option Alert: Ziopharm Oncology January 4 Call; 5,060 Contracts Traded vs 70 Open Interest; Currently $1.77",2013-05-22 15:03:00-04:00,ZIOP,positive
1408579.0,ZIOPHARM Offers Promising Nonclinical and Phase I Study Results of Ad-RTS-IL-12 in Advanced Melanoma at ASGCT 16th Annual Meeting,2013-05-16 07:04:00-04:00,ZIOP,positive
1408580.0,ZIOPHARM Oncology Inc Reports Q1 EPS of $(0.28) vs $(0.27) Est,2013-05-07 16:26:00-04:00,ZIOP,neutral
1408581.0,ZIOPHARM Shares Jump 9+% as Preclinical Data Shows Anti-Tumor Effects in Murine Model,2013-04-09 09:33:00-04:00,ZIOP,positive
1408582.0,"Jefferies Suspends Hold Rating on ZIOPHARM Oncology Inc, Removes $2.00 PT",2013-04-05 16:14:00-04:00,ZIOP,neutral
1408583.0,Stocks Hitting 52-Week Lows,2013-04-04 10:56:00-04:00,ZIOP,negative
1408584.0,UPDATE: Brinson Patrick Downgrades ZIOPHARM Oncology to Market Perform on Palifosfamide Failure,2013-03-27 07:50:00-04:00,ZIOP,negative
1408585.0,Benzinga's Top Downgrades,2013-03-27 07:24:00-04:00,ZIOP,positive
1408586.0,"Brinson Patrick Downgrades ZIOPHARM Oncology Inc to Market Perform, Lowers PT to $1.50",2013-03-27 06:27:00-04:00,ZIOP,negative
1408587.0,"Market Wrap for Tuesday, March 26: Stocks Recoup Monday's Losses; Dow Adds 112",2013-03-26 16:21:00-04:00,ZIOP,negative
1408588.0,"Option Alert: Ziopharm October 3 Call; Block Trade: 9,786 @$0.30; Currently $1.93",2013-03-26 13:15:00-04:00,ZIOP,negative
1408589.0,"Piper Jaffray Downgrades ZIOPHARM Oncology Inc to Underweight, Lowers PT to $1.00",2013-03-26 11:45:00-04:00,ZIOP,negative
1408590.0,"Jefferies Maintains Hold on ZIOPHARM Oncology Inc, Lowers PT to $2.00",2013-03-26 11:05:00-04:00,ZIOP,negative
1408591.0,Stocks Hitting 52-Week Lows,2013-03-26 10:51:00-04:00,ZIOP,negative
1408592.0,Morning Market Losers,2013-03-26 10:39:00-04:00,ZIOP,negative
1408593.0,JP Morgan Downgrades ZIOPHARM Oncology Inc to Neutral,2013-03-26 10:04:00-04:00,ZIOP,positive
1408594.0,"BMO Capital Downgrades ZIOPHARM Oncology Inc to Underperform, Lowers PT to $1.00",2013-03-26 09:07:00-04:00,ZIOP,negative
1408595.0,Ziopharm Falls 55% Pre-Market on Terminatiom of Development of Palifosfamide,2013-03-26 07:20:00-04:00,ZIOP,neutral
1408596.0,A Peek Into The Market Before The Trading Starts,2013-03-26 07:15:00-04:00,ZIOP,neutral
1408597.0,ZIOPHARM Phase 3 Trial of Palifosfamide for Metastatic Soft Tissue Sarcoma Did Not Meet Primary Endpoint,2013-03-26 06:56:00-04:00,ZIOP,neutral
1408598.0,ZIOPHARM Oncology Inc Reports Q4 EPS of $(0.48) vs $(0.29) Est; Revenue of $200.0K vs $170.0K Est; to Report Topline Results from Phase 3 Trial of Palifosfamide at End of March,2013-03-18 16:10:00-04:00,ZIOP,neutral
1408599.0,Ziopharm Shares Spike to Highs on Adam F Tweet,2013-03-14 12:00:00-04:00,ZIOP,positive
1408600.0,Shares of ZIIOPHARM Up After Hours as Bloomberg Incorrectly Reported on SAC Stake in Co.,2013-03-13 16:23:00-04:00,ZIOP,positive
1408601.0,A Peek Into The Market Before The Trading Starts,2013-03-11 07:22:00-04:00,ZIOP,neutral
1408602.0,"ZIOPHARM Initiates Phase 2 Study of Ad-RTS IL-12, Palifosfamide Combination Advanced Breast Cancer Treatment",2013-03-11 06:20:00-04:00,ZIOP,negative
1408603.0,ZIOPHARM Announces Initiation of Phase 2 Study of Palifosfamide in Recurrent and Incurable Germ Cell Tumors ,2013-03-06 06:11:00-05:00,ZIOP,neutral
1408604.0,Ziopharm Shares Spike to Highs on Adam F Tweet,2013-03-04 12:04:00-05:00,ZIOP,positive
1408605.0,Bloomberg Reporting ZIOPHARM CEO Lewis Says Co. in Partnership Talks for Cancer Drug - Bloomberg,2013-02-12 13:43:00-05:00,ZIOP,negative
1408606.0,ZIOPHARM Oncology Shares Charge Higher After Phase 3 Trial of Palifosfamid Reaches Target Number of Progression-Free Survival Events,2013-02-12 10:31:00-05:00,ZIOP,positive
1408607.0,UPDATE: Piper Jaffray Initiates ZIOPHARM Oncology at Neutral on 2013 Cancer Development Outlook  ,2013-01-18 08:08:00-05:00,ZIOP,negative
1408608.0,"Piper Jaffray Initiates Coverage on ZIOPHARM Oncology Inc at Neutral, Announces $5.00 PT",2013-01-17 16:10:00-05:00,ZIOP,neutral
1408609.0,"UPDATE: Jefferies & Company Downgrades ZIOPHARM Oncology to Hold, Lowers PT",2012-12-12 10:09:00-05:00,ZIOP,negative
1408610.0,Benzinga's Top Downgrades,2012-12-12 07:21:00-05:00,ZIOP,positive
1408611.0,"Jefferies Downgrades ZIOPHARM Oncology Inc to Hold, Lowers PT to $4.00",2012-12-12 06:12:00-05:00,ZIOP,negative
1408612.0,Ziopharm Spikes Lower on Negative Seeking Alpha Article,2012-10-26 13:54:00-04:00,ZIOP,negative
1408613.0,ZIOPHARM Provides Update on Phase 1 Study of Ad-RTS IL-12 in Advanced Melanoma ,2012-10-25 06:17:00-04:00,ZIOP,positive
1408614.0,"Option Alert: Ziopharm December 6 Call; Block Trade: 2,000 Contracts @$0.75; Currently $4.72",2012-10-22 09:53:00-04:00,ZIOP,negative
1408615.0,ZIOPHARMA Responds to Negative Blog Post; Say Statements are Misleading and Wrong,2012-10-19 15:02:00-04:00,ZIOP,negative
1408616.0,Ziopharm Spikes Lower on Thursday Forbes Article,2012-10-19 12:34:00-04:00,ZIOP,negative
1408617.0,Options Alert - ZIOPHARM Oncology,2012-10-11 13:10:00-04:00,ZIOP,positive
1408618.0,Options Alert: ZIOPHARM Oncology,2012-10-01 14:32:00-04:00,ZIOP,positive
1408619.0,A Peek Into The Market Before The Trading Starts,2012-08-02 08:39:00-04:00,ZIOP,neutral
1408620.0,A Peek Into The Market Before The Trading Starts,2012-08-02 07:55:00-04:00,ZIOP,neutral
1408621.0,ZIOPHARM Oncology Granted New U.S. Patent for Palifosfamide ,2012-08-02 06:50:00-04:00,ZIOP,positive
1408622.0,ZIOPHARM Oncology Announces New Executive Team  ,2012-07-16 16:06:00-04:00,ZIOP,neutral
1408623.0,"BMO Capital Markets Reiterates Market Perform Rating, $6 PT for ZIOPHARM Oncology",2012-06-27 11:36:00-04:00,ZIOP,neutral
1408624.0,UPDATE: Jefferies Increases PT on ZIOPHARM to $7 ,2012-06-20 09:38:00-04:00,ZIOP,neutral
1408625.0,"Jefferies & Company Raises PT on ZIOPHARM Oncology from $6 to $7, Maintains Buy",2012-06-20 06:57:00-04:00,ZIOP,neutral
1408626.0,ZIOPHARM Oncology Announces Dosing of First Patient in Phase 3 Study of Palifosfamide for the Treatment of Small Cell Lung Cancer ,2012-06-11 06:34:00-04:00,ZIOP,negative
1408627.0,"Option Alert: Ziopharm Oncology Call Volume at 1,351% of Average; Currently $5.08",2012-06-06 14:54:00-04:00,ZIOP,positive
1408628.0,ZIOPHARM Oncology Completes Enrollment in PICASSO 3 Trial ,2012-06-02 10:32:00-04:00,ZIOP,neutral
1408629.0,UPDATE: JP Morgan Initiates Overweight on ZIOPHARM Oncology; Standard Bearing Asset  ,2012-05-18 11:10:00-04:00,ZIOP,positive
1408630.0,"Option Alert: Ziopharm Oncology Put Volume at 1,841% of Average; Currently $4.50",2012-05-18 10:11:00-04:00,ZIOP,positive
1408631.0,"JP Morgan Initiates Coverage on Ziopharm Oncology at Overweight, Announces PT of $7",2012-05-18 06:37:00-04:00,ZIOP,neutral
1408632.0,ZIOPHARM Oncology Appoints Jason A. Amello as Executive Vice President and Chief Financial Officer ,2012-05-08 06:36:00-04:00,ZIOP,neutral
1408633.0,Ziopharm Says Picasso 3 Trial Approaches 90% Completion,2012-04-02 08:58:00-04:00,ZIOP,neutral
1408634.0,"Canaccord Initiates Coverage on Ziopharm Oncology at Buy, Announces PT of $9",2012-03-26 08:57:00-04:00,ZIOP,neutral
1408635.0,UPDATE: Jefferies Reduces PT to $6 on ZIOPHARM Oncology,2012-03-02 11:07:00-05:00,ZIOP,neutral
1408636.0,"Jefferies & Company Maintains Ziopharm Oncology at Buy, Lowers PT from $7 to $6",2012-03-02 09:02:00-05:00,ZIOP,negative
1408637.0,Ziopharm Oncology Reports Q4 EPS $-0.24 vs $-0.26 Est,2012-03-01 07:07:00-05:00,ZIOP,neutral
1408638.0,Collins Stewart: Palifosfamide P2 OS Data Bodes Well for P3,2012-02-13 10:13:00-05:00,ZIOP,positive
1408639.0,ZIOPHARM Oncology Reports Positive Preliminary Palifosfamide Overall Survival Data From Randomized Phase 2 Study in Soft Tissue Sarcoma ,2012-02-13 06:45:00-05:00,ZIOP,positive
1408640.0,A Peek Into The Market Before The Trading Starts,2012-02-06 07:24:00-05:00,ZIOP,neutral
1408641.0,ZIOPHARM Announces FDA Acceptance of IND for Oral Palifosfamide  ,2012-02-06 06:41:00-05:00,ZIOP,positive
1408642.0,ZIOPHARM Oncology Announces Recommendation by Independent Data Monitoring Committee to Continue Phase 3 Study of Palifosfamide in Metastatic Soft Tissue Sarcoma ,2012-01-30 06:41:00-05:00,ZIOP,neutral
1408643.0,ZIOPHARM Oncology Prices Public Offering of Common Stock at $5.20 per Share,2012-01-20 09:28:00-05:00,ZIOP,positive
1408644.0,ZIOPHARM Oncology Announces Proposed Public Offering of Common Stock; No Amount Given   ,2012-01-19 16:07:00-05:00,ZIOP,negative
1408645.0,From  Earlier: ZIOPHARM Oncology Files Complaint Against Former Employees ,2011-12-23 07:11:00-05:00,ZIOP,negative
1408646.0,"Global Hunter Initiates ZIOPHARM Oncology at Buy, $9 PT",2011-12-15 07:29:00-05:00,ZIOP,neutral
1408647.0,ZIOPHARM Granted European Patent Allowance for Palifosfamide   ,2011-12-07 06:37:00-05:00,ZIOP,positive
1408648.0,Notable Put Options Activity in ZIOPHARM Oncology,2011-11-22 11:34:00-05:00,ZIOP,neutral
1408649.0,ZIOPHARM Oncology Announces Promising Data from Phase 1b Study of Palifosfamide in Small Cell Lung and Other Cancers at AACR-NCI-EORTC Meeting ,2011-11-14 15:30:00-05:00,ZIOP,positive
1408650.0,Ziopharm Oncology Files $150M Mixed Securities Shelf,2011-11-07 16:27:00-05:00,ZIOP,positive
1408651.0,ZIOPHARM Presents Promising Preclinical Pediatric Sarcoma Data with Oral and IV Palifosfamide at the 2011 CTOS/MSTS Meeting   ,2011-10-28 12:44:00-04:00,ZIOP,positive
1408652.0,ZIOPHARM Oncology Announces First Patient Dosed in Phase I Study of ZIN ATI-001 in Advanced Melanoma  ,2011-08-30 06:57:00-04:00,ZIOP,positive
1408653.0,"Monday's NASDAQ Top Percentage Gainers: BroadSoft, Globalstar, ZIOPHARM, Novatel Wireless",2011-08-09 11:44:00-04:00,ZIOP,positive
1408654.0,Edison Investment Provides Color on Ziopharm Oncology,2011-06-29 06:03:00-04:00,ZIOP,neutral
1408655.0,"Ziopharm Reports Initial Positive Data Presented at 2011 Asco, Zin-cti-001 Well Tolerated",2011-06-10 07:44:00-04:00,ZIOP,positive
1408656.0,Ziopharm Reports Initial Positive Data Presented at 2011 Asco,2011-06-06 09:01:00-04:00,ZIOP,positive
1408657.0,ZIOPHARM Oncology Announces Filing of Resale Registration Statement for Previous Private Placement ,2011-05-18 09:58:00-04:00,ZIOP,neutral
1408658.0,Small Cap Stock on the Move (ZIOP) triple top break out new high above $6.50,2011-04-06 11:35:00-04:00,ZIOP,positive
1408659.0,Options Brief: ZIOPHARM Oncology (ZIOP),2011-03-23 10:43:00-04:00,ZIOP,neutral
1408660.0,"Jefferies Initiates ZIOPHARM At Buy, $8 PT",2011-02-09 07:57:00-05:00,ZIOP,neutral
1408661.0,ZIOPHARM Prices Public Offering at $5.75 per Share,2011-02-03 09:19:00-05:00,ZIOP,positive
1408662.0,ZIOPHARM Announces Proposed Public Offering of 9.6M Shares,2011-02-02 16:17:00-05:00,ZIOP,positive
1408663.0,A Peek Into The Market Before The Trading Starts,2011-01-20 08:06:00-05:00,ZIOP,neutral
1408664.0,ZIOPHARM Receives Positive Opinion for Darinaparsin from European Medicines Agency ,2011-01-20 07:15:00-05:00,ZIOP,positive
1408665.0,Ziopharm CEO Appears On Bloomberg TV,2011-01-13 15:23:00-05:00,ZIOP,neutral
1408666.0,ZIOPHARM Oncology Climbs 8.3% ( ZIOP),2011-01-12 15:06:00-05:00,ZIOP,neutral
1408667.0,ZIOPHARM Oncology and Intrexon Announce Worldwide Partnership (ZIOP),2011-01-06 16:13:00-05:00,ZIOP,neutral
1408668.0,ZIOP Initiates Cancer Study - Analyst Blog,2010-12-30 10:33:00-05:00,ZIOP,negative
1408669.0,ZIOP Initiates Cancer Study - Analyst Blog,2010-12-30 09:45:00-05:00,ZIOP,negative
1408670.0,Calls Purchased As ZIOPHARM Oncology Pops (ZIOP),2010-12-21 13:59:00-05:00,ZIOP,neutral
1408671.0,ZIOPHARM Reports Third Quarter Financial Results and Updates Clinical Programs   ,2010-11-04 08:36:00-04:00,ZIOP,neutral
1408672.0,"ZIOPHARM Oncology Awarded $733,000 Grant ",2010-11-02 12:16:00-04:00,ZIOP,positive
1408673.0,Calls Purchased on ZIOPHARM Oncology (ZIOP),2010-10-05 15:52:00-04:00,ZIOP,neutral
1408674.0,"ZIOPHARM Oncology Appoints Michael G. King, Jr. as Senior Vice President ",2010-10-01 07:56:00-04:00,ZIOP,neutral
1408675.0,ZIOPHARM Announces Initiation of Palifosfamide Pivotal Study,2010-07-19 16:06:00-04:00,ZIOP,neutral
1408676.0,Ziopharm Oncology (ZIOP) Shares Fall 10%,2010-05-26 19:43:00-04:00,ZIOP,positive
1408677.0,ZIOP Initiated With Outperform,2010-02-18 08:51:00-05:00,ZIOP,neutral
1408678.0,Ziopharm To Raise $45.2 In Stock Offering (ZIOP),2009-12-04 14:41:00-05:00,ZIOP,neutral
1408679.0,"Benzinga’s Biggest Losers (TTWO, SWHC, STE, BCON, ZIOP)",2009-12-04 11:59:00-05:00,ZIOP,negative
1408680.0,"New 52-Week High (DRAM,ZIOP,RDY,BVF,SLH)",2009-09-25 12:43:00-04:00,ZIOP,neutral
